Thank You for reading

We have just posted a new story

• A cure for cystic fibrosis? Dutch scientist Hans Clevers and colleagues from Utrecht have used CRISPR base editors to cure cystic fibrosis in mini-organs derived from patient stem cells. Encouragingly no off-target effects were found, and the gene therapy may be safe to use for repairing damaged tissue.

Other great reads

• Interview with Marcello Maresca, associate director at AstraZeneca, on CRISPR in vivo genome editing with no detectable off-target mutations.
• Immunotherapy pioneer Carl June and other experts talks to us about the first CRISPR gene therapy and how the data show it is safe.

Thank You for now - more great reads are on the way.

And if you have questions or suggestions, you can directly reach us at editor@crisprmedicinenews.com. We love hearing from readers!

(c; Rasmus

You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.